ABBV Jan 2025 220.000 call

OPR - OPR Delayed Price. Currency in USD

Add to watchlist

2.6300

0.0000

(0.00%)

At close: 12:54PM EDT

Motley Fool
Could This Drug News Lift AbbVie's Stock?
Consider AbbVie's (NYSE: ABBV) crown jewel drug, Humira, which hauled in $21.2 billion in revenue in 2022. The good news is that AbbVie knew this day would come and has been preparing. SLE is an autoimmune disease that affects multiple organs of the body.
Simply Wall St.
AbbVie Inc. (NYSE:ABBV) insiders sold US$6.3m worth of stock, possibly signalling a downtrend
In the last year, many AbbVie Inc. ( NYSE:ABBV ) insiders sold a substantial stake in the company which may have...
Motley Fool
The Top Healthcare Stocks to Buy With $100
A common misconception is that you need a lot of money to invest in the stock market. Let's look at three healthcare stocks that can be purchased for $100 and have good prospects to grow over time. The stock hasn't been off to a great start this year, dipping 18%, but the odds look pretty good for the company in the near future.